跳至主要内容
临床试验/DRKS00020942
DRKS00020942招募中不适用

Evaluating the feasibility and accuracy of novel intra-operative molecular imaging with two PSMA-tracers in prostate cancer - CLI AI PSMA

Klinik und Poliklinik für Urologie, Kinderurologie und Uroonkologie Universitätsklinikum Essen0 个研究点目标入组 40 人开始时间: 2020年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • Male = 18 years of age
  • Histologically confirmed adenocarcinoma of the prostate
  • High-risk for positive surgical margins
  • a. cT3 stage according to TNM classification, or
  • b. ISUP Gleason grade group 4/5, or
  • c. PSA >15 ng/ml
  • Indication for radical prostatectomy
  • Preoperative PCa staging performed according to current guidelines

排除标准

  • Known hypersensitivity to the diagnostic PET agent or its components
  • Administration of any kind of PET tracer within a period corresponding to 8 half-lives of the respective radionuclide
  • Subjects not able to declare meaningful informed consent on their own (e.g. with legal guardian for mental disorders)
  • Evidence of neuroendocrine small cell prostate cancer
  • Polytope metastases on conventional imaging as per CHAARTED criteria (visceral metastases or =4 bone metastases including at least one outside the axial skeleton)

研究者

发起方
Klinik und Poliklinik für Urologie, Kinderurologie und Uroonkologie Universitätsklinikum Essen

相似试验